
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Incannex Healthcare Limited is a drug manufacturers—specialty & generic business based in Australia. Impression Healthcare shares (IHL) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Impression Healthcare has a trailing 12-month revenue of around $609,429..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.029 - $0.097 |
---|---|
50-day moving average | $0.0687 |
200-day moving average | $0.0597 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.006 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.08 on 2020-10-22
1 week (2021-01-14) | -54.29% |
---|---|
1 month (2020-12-21) | -44.83% |
3 months (2020-10-21) | -10.11% |
6 months (2020-07-21) | 14.29% |
1 year (2020-01-21) | 6.67% |
---|---|
2 years (2019-01-21) | 280.95% |
3 years (2018-01-19) | 250.88% |
5 years (2016-01-21) | 11.27% |
Revenue TTM | $609,429 |
---|---|
Gross profit TTM | $159,084 |
Return on assets TTM | -97.13% |
Return on equity TTM | -286.05% |
Profit margin | 0% |
Book value | 0.004 |
Market capitalisation | $85 million |
TTM: trailing 12 months
We're not expecting Impression Healthcare to pay a dividend over the next 12 months.
Impression Healthcare 's shares were split on a 1:20 basis on 29 July 2016. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Impression Healthcare shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Impression Healthcare shares which in turn could have impacted Impression Healthcare 's share price.
Over the last 12 months, Impression Healthcare 's shares have ranged in value from as little as $0.029 up to $0.097. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Impression Healthcare 's is 1.4278. This would suggest that Impression Healthcare 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's therapeutic products in clinical trials include IHL-42X for obstructive sleep apnea; IHL-216A for traumatic brain injury; IHL-675A for sepsis associated acute respiratory distress syndrome; and IHL-493C for temporomandibular joint dysfunction. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited is based in Castle Hill, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.